A landmark study presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting has revealed something extraordinary. Women taking GLP-1 drugs like Ozempic and Wegovy were roughly 30% less likely to develop breast cancer – a finding that is reshaping how doctors think about these blockbuster weight-loss medications. What the Study Found Researchers […]
